Hair loss is a common concern for many people, but the mindset of “waiting a bit longer to treat it” often turns a controllable problem into a tricky one. From a medical perspective, the key to treating hair loss lies in one word: “early.” The earlier the intervention, the better the results. This is supported by clear scientific evidence.
The most common type of hair loss is androgenetic alopecia (also known as seborrheic alopecia), which affects hundreds of millions of people worldwide. The core mechanism of this type of hair loss is that hair follicles in genetically predisposed individuals are abnormally sensitive to androgens (especially dihydrotestosterone, or DHT). DHT continuously attacks the hair follicles, causing them to gradually miniaturize—thick, long hairs become thin, fine vellus hairs, and eventually the hair follicles close completely, ceasing to produce any visible hair.
This miniaturization process does not happen overnight. Before the hair follicle completely atrophies, it goes through a long “reversible phase.” In the early stages, the hair follicle’s growth cycle simply shortens, the hair becomes finer, and density decreases—but the follicle itself is still alive. If intervention occurs in time during this stage, it is entirely possible to reverse the miniaturization and restore the hair follicle to a healthy state. Once a hair follicle has fully fibrosed and disappeared, no medication can revive it—transplant surgery can only “move” healthy follicles from other areas, but it cannot regrow hair from a follicle that has already died.
This explains the fundamental reason why “the earlier the intervention, the better the outcome”: early treatment preserves existing hair follicles and prevents them from dying. If you wait until the scalp is visibly bald and the follicular openings are completely exposed before starting medication, those already closed areas will permanently lose the chance to regrow hair. Drugs can only maintain the follicles that have not yet fully atrophied in the surrounding areas.
Currently, the two treatment regimens with the strongest evidence from evidence-based medicine and most widely recommended by international guidelines are topical minoxidil and oral finasteride (for men). Minoxidil stimulates hair follicles to prolong the growth phase and helps revive miniaturized follicles; finasteride inhibits 5α-reductase, reducing DHT levels in the blood and scalp, thereby fundamentally slowing the attack on hair follicles. The efficacy of these two drugs has been validated in numerous randomized controlled trials, but their best results are achieved in the early stages, before the follicles have been completely destroyed.
Research data indicates that after starting treatment, it typically takes 6–12 months of continuous use to see noticeable improvement, and the effects gradually diminish after stopping the medication. Therefore, early treatment means longer follicle survival, fewer follicles that need to be “rescued,” and a better chance of achieving goals such as restoring hair volume and slowing further hair loss. Conversely, delaying treatment not only results in the loss of already necrotic follicles but also exposes the surviving follicles to years of additional harm. Even with later medication use, complete recovery may not be possible.
It is important to note that not all types of hair loss are suitable for the same intervention strategy. For example, alopecia areata (commonly known as “spot baldness”) is an autoimmune disease; some patients may recover spontaneously, but those who do not heal for a long time or experience recurrent episodes should also seek evaluation by a dermatologist as early as possible to prevent progression to total or universal alopecia. Scarring alopecia (such as that caused by discoid lupus erythematosus) requires controlling the underlying disease; otherwise, hair follicles will be permanently damaged. Therefore, the most important first step is to consult a doctor for a definitive diagnosis, rather than self-guessing or relying on folk remedies.
In addition, the vast majority of “anti-hair-loss shampoos” and “hair-growth supplements” circulating online lack support from high-quality clinical trials. Only a few ingredients (such as specific concentrations of caffeine, ketoconazole, etc.) have shown weak adjunctive effects in small studies, but they are far from being substitutes for standard treatments. Patients should be wary of exaggerated claims and avoid delaying real treatment opportunities by using ineffective products.
In summary, the “golden window” for treating hair loss is while the hair follicles are still alive. Once you notice a receding hairline, thinning on the crown, widening of the part, or a significant increase in hair shedding, it is advisable to visit a dermatologist as soon as possible. Through history-taking, the hair pull test, trichoscopy, and even hair microscopy, the doctor can help determine the type and stage of hair loss. Early diagnosis, early medication, and long-term adherence are the keys to preserving more hair.
(For reference only, does not constitute medical advice.)